Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1998-04-09
2000-12-26
Lambkin, Deborah C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514545, 514448, 514422, 514423, 562459, 560 51, 549 70, 548527, 548530, 548531, A61K 3119, A61K 31235, A61K 3138, C07C 5974, C07D40900
Patent
active
061660825
ABSTRACT:
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula
REFERENCES:
patent: 3182061 (1965-05-01), Goldschmidt
patent: 3624142 (1971-11-01), Shen et al.
patent: 3652646 (1972-03-01), Leigh et al.
patent: 3707549 (1972-12-01), Mills
patent: 3749750 (1973-07-01), Wei
patent: 3754021 (1973-08-01), Shen et al.
patent: 3784701 (1974-01-01), Tomcufcik et al.
patent: 3867434 (1975-02-01), Diamond
patent: 3876800 (1975-04-01), Krausz et al.
patent: 3882174 (1975-05-01), Seeger et al.
patent: 3917846 (1975-11-01), Diamond et al.
patent: 3962228 (1976-06-01), Wei et al.
patent: 3993683 (1976-11-01), Nickl et al.
patent: 3997589 (1976-12-01), Seeger et al.
patent: 4008323 (1977-02-01), Cousse et al.
patent: 4021479 (1977-05-01), Seeger et al.
patent: 4049823 (1977-09-01), Schacht et al.
patent: 4058558 (1977-11-01), Cousse et al.
patent: 4151302 (1979-04-01), Gante et al.
patent: 4168385 (1979-09-01), Trust et al.
patent: 4219668 (1980-08-01), Chiccarelli
patent: 4247466 (1981-01-01), Chiccarelli
patent: 4271191 (1981-06-01), Mazoyer
patent: 4304788 (1981-12-01), Edge
patent: 4310544 (1982-01-01), Edge
patent: 4472316 (1984-09-01), Sota et al.
patent: 4577025 (1986-03-01), Arai et al.
patent: 4594197 (1986-06-01), Tomisawa et al.
patent: 4683331 (1987-07-01), Kuchar et al.
patent: 4933367 (1990-06-01), Wolff et al.
patent: 4937243 (1990-06-01), Markwell et al.
patent: 5098613 (1992-03-01), Bollinger et al.
patent: 5109000 (1992-04-01), Markwell et al.
patent: 5124322 (1992-06-01), Hughes
patent: 5177204 (1993-01-01), Kuchar et al.
patent: 5217996 (1993-06-01), Ksander
patent: 5250552 (1993-10-01), Boschelli et al.
patent: 5273990 (1993-12-01), De Lombaert
patent: 5462954 (1995-10-01), Baker et al.
patent: 5473100 (1995-12-01), Isomura et al.
patent: 5525629 (1996-06-01), Crimmin et al.
patent: 5591891 (1997-01-01), Fourmie-Zaluski et al.
patent: 5629343 (1997-05-01), Hagmann et al.
patent: 5648524 (1997-07-01), Wang et al.
patent: 5658944 (1997-08-01), Chapman, Jr. et al.
patent: 5668176 (1997-09-01), Bagley et al.
patent: 5714515 (1998-02-01), Bunger
patent: 5736559 (1998-04-01), Himmelsbach et al.
patent: 5760276 (1998-06-01), Beard et al.
patent: 5776977 (1998-07-01), Naik et al.
patent: 5789434 (1998-08-01), Kluender et al.
Chiccarelli et al., "Disposition and Metabolism of Fenbufen in several Laboratory Animals", Arzneim.-Forsch./Drug Res., 30(I): 707-715 (1980).
Child et al., "A New Non-steroidal Anti-inflammatory Analgesic: .gamma.-Oxo (1,1'-biphenyl)-4-butanoic Acid (Fenbufen)", Arzneim.-Forsch./Drug Res., 30(I): 695-702 (1980).
Child et al., "Fenbufen, a New Anti-Inflammatory Analgesic: Synthesis and Structure-Activity Relationships of Analogs", J. Pharma. Sci., 66(4): 466-476 (1977).
Cousse et al., "Synthese, structure et activite hypocholesteoleminate d'une serie d'acides .gamma.-aryl, .gamma.-oxo butyriques substitues et deriees", Eur. J. Med. Chem., 22: 45-57 (1987).
Curran, W. V. and Ross, A., "6-Phenyl-4,5-dihydro-3(2H)-pyridazinones. A Series of Hypotensive Agents", J. Med. Chem., 17(3): 273-281 (1974).
El-Hashash et al., "Reactions of 3,5-Disubstituted-2-Furanone with Amines, Grignard Reagents, Toluene and Xylene", Indian Journal of Heterocyclic Chemistry, 5: 231-232 (1996).
Fournel et al., "Differential induction profile of drug-metabolizing enzimes after treatment with hypolipidemic agents", Xenobiotica, 17(4): 445-457 (1987).
Kameo et al., "studies on Antirheumatic Agents: 3-Benzoylpropionic Acid Derivatives", Chem. Pharm. Bull., 36(6): 2050-2060 (1988).
Kameo et al., "Studies on Hypolipidemic Agents. IV. 3-[4-(Phenylthio)benzoyl] propionic Acids Derivatives", Chem.Pharm. Bull., 37(5): 1260-1267 (1989).
Kawashima et al., "Structure-Activity Studies of 3-Benzoylpropionic Acid Derivatives Suppressing Adjuvant Arthritis", Chem. Pharm. Bull., 40(3): 774-777 (1992).
Kuchar et al., "Quantitiative Relations Between Structure and Anti Inflammatory Activity of Ayloxoalkanoic Acids", Collection Czechoslovak Chem.Commun., 53: 1862-1872 (1988).
Sammour et al., "Akylation of Aromatic Hydrocarbons with .beta.-Aroylacrylic Acids", J. Prakt.Chemie, 314(5-6): 906-914 (1972).
Takeshita et al., "Immunopharmacological Studies of New 3-Benzoyl-4-Mercaptobutyric Acid Derivatives. II Immunosuppressive Effects", Drugs Exptl.Clin.Res., XIV(5): 311-318 (1988).
Tomisawa et al., "Studies on Hypolipidemic Agents. II. 3-(4-Phenoxybenzoyl)-propionic Acid Derivatives", Chem. Pharm. Bull., 33(6) 2386-2394 (1985).
Weizmann et al.,"A New Method for the Synthesis of .beta.-Phenyl-Naphthalene Derivatives", Chemistry and Industry, pp. 402-404 (Jun. 8, 1940).
Chem.Abstr. Accession No. 108: 131724k. Tamam, et al., "Alkylation of indole with .beta.-aroylacrylic acids and some studies on the alkylated products", Egypt J. Chem., 28(4): 341-351 (1986).
Chem.Abstr. Accession No. 108: 112129d. Tamam, et al., "Alkylation of indole with .beta.-aroylacrylic acids and some studies on the alkylated products", J. Chem. Soc. Pak., 9(1): 1-10 (1987).
Chem.Abstr. Accession No. 108: 31304. Kuchar, et al., "Metabolic Model and QSAR of Long-acting Anti-inflammatory Arylaliphatic Acids", (1987).
Chem. Abst., 30: 7729.sup.3 (1936), Farbenind, I. G., "Compounds having capillary action".
Chem.Abstr., Accession No. 119: 270810a (1993). Kaender, G., "Preparation of biaryl substituted 4-amino-butyric acids amides".
Chem.Abstr., Accession No. 120: 164483g (1994). De Lombaert, S., "Preparation of (phosphonomethyl)aminoalkanoases as neutral endopeptidase inhibitors".
Chem.Abstr., Accession No. 120: 245512t (1994). De Lombaert, S., "Preparation of tetrazolylalkylaminomethylphosphonates as neutral endopeptidase inhibitors".
Benz Guenter Hans Heinz Herbert
Brittelli David Ross
Bullock William Harrison
Combs Kerry Jeanne
Dixon Brian Richard
Bayer Corporation
Lambkin Deborah C.
LandOfFree
Substituted 5-biarylpentanoic acids and derivatives as matrix me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 5-biarylpentanoic acids and derivatives as matrix me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 5-biarylpentanoic acids and derivatives as matrix me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-995501